Published in
American Society for Clinical Investigation, Journal of Clinical Investigation, 7(131), 2021
DOI: 10.1172/jci140690
Links
Tools
Prostaglandin I2 signaling licenses Treg suppressive function and prevents pathogenic reprogramming
Journal article published in 2021 by
Allison E. Norlander 
,
Shinji Toki ,
Jian Zhang,
Weisong Zhou,
Vasiliy V. Polosukhin,
Vivek D. Gandhi,
Lisa M. Rogers,
Janey Wang,
Dawn C. Newcomb,
Melissa H. Bloodworth,
R. Stokes Peebles Jr,
Kelli L. Boyd,
Jacqueline-Yvonne Cephus,
Zachary J. Ceneviva,
Louis-Marie Charbonnier
and other authors.
,
Shinji Toki ,
Jian Zhang,
Weisong Zhou,
Vasiliy V. Polosukhin,
Vivek D. Gandhi,
Lisa M. Rogers,
Janey Wang,
Dawn C. Newcomb,
Melissa H. Bloodworth,
R. Stokes Peebles Jr,
Kelli L. Boyd,
Jacqueline-Yvonne Cephus,
Zachary J. Ceneviva,
Louis-Marie Charbonnier
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 